Abstract

Cyclic nucleotide‐gated channel β1 (CNGB1) encodes the 240‐kDa β subunit of the rod photoreceptor cyclic nucleotide‐gated ion channel. Disease‐causing sequence variants in CNGB1 lead to autosomal recessive rod‐cone dystrophy/retinitis pigmentosa (RP). We herein present a comprehensive review and analysis of all previously reported CNGB1 sequence variants, and add 22 novel variants, thereby enlarging the spectrum to 84 variants in total, including 24 missense variants (two of which may also affect splicing), 21 nonsense, 19 splicing defects (7 at noncanonical positions), 10 small deletions, 1 small insertion, 1 small insertion–deletion, 7 small duplications, and 1 gross deletion. According to the American College of Medical Genetics and Genomics classification criteria, 59 variants were considered pathogenic or likely pathogenic and 25 were variants of uncertain significance. In addition, we provide further phenotypic data from 34 CNGB1‐related RP cases, which, overall, are in line with previous findings suggesting that this form of RP has long‐term retention of useful central vision despite the early onset of night blindness, which is valuable for patient counseling, but also has implications for it being considered a priority target for gene therapy trials.

Highlights

  • Inherited retinal diseases (IRDs) are a group of clinically and genetically heterogeneous disorders with an overall estimated prevalence that ranges between 1/3500 and 1/5000 worldwide

  • Most of the proteins encoded by these genes are involved in cellular pathways that are crucial for photoreceptor or retinal pigment epithelium (RPE) homeostasis and functions (Wright et al, 2010)

  • Winkler et al (2013) discovered a canine model of progressive retinal degeneration connected with a spontaneous variant in Cngb1, which closely resembled the Cngb1‐X26 mouse model and the human RP45 phenotype

Read more

Summary

Funding information

Agence Nationale de la Recherche, Grant/Award Numbers: ANR‐10‐LABX‐65, ANR‐11‐IDEX‐0004‐0, ANR‐18‐IAHU‐0001; National Eye Institute, Grant/Award Number: R24EY027285; National Institute for Health Research; Foundation Fighting Blindness, Grant/Award Numbers: C‐CMM‐0907‐0428‐ INSERM04, CD‐CL‐0619‐0759‐INSERM; Wellcome Trust, Grant/Award Number: 206619/Z/17/Z; Research to Prevent Blindness

| BACKGROUND
| Literature search
Findings
| CONCLUSIONS AND FUTURE DIRECTIONS
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.